Adjuvant hyperbaric oxygen therapy (HBO2)for... (2005 study) Skip to main content
Retrospective Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2005

Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate.

Escobar SJ, Slade JB, Hunt TK, Cianci P, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2005

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the records of 42 patients with a severe, fast-spreading soft tissue infection called necrotizing fasciitis, who were treated with hyperbaric oxygen therapy (HBO2) added to surgery, antibiotics and intensive care.

What They Found

This retrospective study of 42 patients with necrotizing fasciitis treated with adjunctive HBO2 found a mortality of 11.9% (5 patients) and no amputations after arrival at the treating center. Two amputations (a finger and a penis) happened before patients were transported there. Patients had an average of 2.8 surgical debridements, 1.25 of them before HBO2 started, and the infection was controlled after an average of 7 HBO2 treatments. Mild ear barotrauma occurred in 3 patients (7%) and confinement anxiety in 17 (41%), but neither prevented treatment.

What This Means for Canadian Patients

For people with necrotizing fasciitis, this abstract describes outcomes in one group who received HBO2 alongside surgery, antibiotics and critical care. The authors compared their results with national reports and saw lower mortality and fewer amputations, but the study had no control group and the abstract reports no statistical test of that comparison. It also reports that HBO2 did not delay surgery or interfere with standard treatment. Ear pressure injury and anxiety about being enclosed in the chamber were the side effects reported.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective review of 42 patients at one referral center with no control group, so it cannot show that HBO2 caused the lower mortality and amputation rates, and the comparison with national reports (34% versus 11.9% mortality) was not backed by a statistical test in the abstract.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Wound Care
Source Pubmed
PubMed ID 16509286
Year Published 2005
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Adult; Aged; Aged, 80 and over; Amputation, Surgical; Combined Modality Therapy; Debridement; Fasciitis, Necrotizing; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Retrospective Studies

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology